(NP (NP (NP (JJ Natural) (NNS variants)) (PP (IN of) (NP (DT the) (NN HIV-1) (JJ long) (JJ terminal) (NN repeat))) (: :)) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS promoters)) (PP (IN with) (NP (JJ duplicated) (NN DNA) (JJ regulatory) (NNS motifs))))) (. .)))
(S (NP-SBJ-1 (NP (NN Sequence) (NN variation)) (PP (IN in) (NP (NP (DT the) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))) (NN region)) (PP (IN of) (NP (NN HIV-1)))))) (VP (VBD was) (VP (VBN analyzed) (NP (-NONE- *-1)) (PP (IN in) (NP (NP (JJ viral) (NNS isolates)) (PP (IN of) (NP (CD 17) (JJ infected) (NNS individuals))))))) (. .))
(S (NP-SBJ-2 (NP (CD Two) (NNS classes)) (PP (IN of) (NP (NN LTR) (NN size) (NNS variants)))) (VP (VBD were) (VP (VBN found) (NP (-NONE- *-2)))) (. .))
(S (NP-SBJ-3 (CD One) (NN HIV-1) (NN variant)) (VP (VBD was) (VP (VBN detected) (S-ADV (NP-SBJ (-NONE- *-3)) (VP-4 (VBG containing) (NP (NP (DT an) (JJ additional) (VBG binding) (NN site)) (PP (IN for) (NP (DT the) (NN transcription) (NN factor) (NN Sp1)))))))) (. .))
(S (NP-SBJ-5 (DT Another) (NN LTR) (NN size) (NN variation)) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-5)) (PP (IN in) (NP (CD four) (NNS patients))) (PP (IN in) (NP (NP (DT a) (NN region)) (ADJP (RB just) (JJ upstream) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN enhancer)))))))) (. .))
(S (NP-SBJ (DT This) (NN variation)) (VP (VBD was) (NP-PRD (NP (DT the) (NN result)) (PP (IN of) (NP (NP (DT a) (NN duplication)) (PP (IN of) (NP (NP (DT a) (JJ short) (NN DNA) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN CTG-motif)) (-RRB- -RRB-)))))))) (. .))
(S (NP-SBJ (NN Cell) (NN culture) (NNS experiments)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ natural) (NN variant)) (PP (IN with) (NP (CD four) (NN Sp1) (NNS sites)))) (VP (VBD had) (NP (NP (DT a) (ADJP (RB slightly) (JJR higher)) (NP-COOD (NP (NN promoter) (NN activity)) (CC and) (NP (JJ viral) (NN replication) (NN rate)))) (PP (IN than) (NP (NP (DT the) (JJ isogenic) (NN control) (NN LTR)) (PP (IN with) (NP (CD three) (NN Sp1) (NNS sites)))))))))) (. .))
(S (NP-SBJ-6 (NP (DT No) (JJ positive) (NN effect)) (PP (IN of) (NP (DT the) (JJ duplicated) (NN CTG-motif)))) (VP (MD could) (VP (VB be) (VP (VBN detected) (NP (-NONE- *-6))))) (. .))
(S (SBAR-ADV (IN In) (NN order) (TO to) (S (NP-SBJ (-NONE- *)) (VP (VB measure) (NP (NP (JJ small) (NNS differences)) (PP (IN in) (NP (NN virus) (NN production)))) (ADVP (RBR more) (RB accurately))))) (, ,) (NP-SBJ-7 (NP (JJ equal) (NNS amounts)) (PP (IN of) (NP-COOD (NP (DT a) (NN size) (NN variant)) (CC and) (NP (DT the) (JJ wild-type) (NN plasmid))))) (VP (VBD were) (VP (VBN cotransfected) (NP (-NONE- *-7)) (PP (IN into) (NP (NNS T-cells))))) (. .))
(S-COOD (S (NP-SBJ (NP (DT The) (NN virus)) (PP (IN with) (NP (CD four) (NN Sp1) (NNS sites)))) (VP (VBD did) (VP (VB outgrow) (NP (DT the) (CD three) (NN Sp1) (NN virus)) (PP-TMP (IN in) (NP (NP (CD 35) (NNS days)) (PP (IN of) (NP (NN culture)))))))) (CC and) (S (NP-SBJ (NN CTG-monomer) (NN virus)) (VP (VBD outcompeted) (NP (DT the) (NN CTG-dimer) (NN virus)) (PP-TMP (IN in) (NP (CD 42) (NNS days))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (DT these) (NNS results)))) (NP-SBJ (PRP we)) (VP (VBP estimate) (NP (NP (DT a) (ADJP (QP (CD 5-10)) (NN %)) (NN difference)) (PP (IN in) (NP-8 (NP (NN virus) (NN production)) (PP (IN of) (NP (DT the) (NN LTR) (NNS variants)))))) (SBAR-TMP (WHADVP-10 (WRB when)) (S (NP-SBJ-9 (-NONE- *)) (VP (VBN compared) (NP (-NONE- *-9)) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NN wild-type))))) (ADVP (-NONE- *T*-10)))))) (. .))
